Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-FR Version v7-EN
Language French English
Date Updated 2022-01-06 2021-08-24
Drug Identification Number 00716731 00716731
Brand name TARO-DOCUSATE TARO-DOCUSATE
Common or Proper name DOCUSATE SODIUM DOCUSATE SODIUM
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients DOCUSATE SODIUM DOCUSATE SODIUM
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code A06AA A06AA
ATC description DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2021-07-29 2021-07-29
Estimated end date 2021-12-23 2021-10-01
Actual end date 2022-01-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments